Research Article

Fecal Microbiota Transplantation for Clostridioides Difficile Infection in Patients with Chronic Liver Disease

Table 2

Response to FMT, stratified by liver disease status.

Liver disease ()No liver disease () value

Age59.5 (47.5-73.0)72.0 (54.0-83.0)0.17
Sex
 Male4 (33.3)68 (41.5)0.76
 Female8 (66.7)96 (58.5)
CDI severity
 Severe3 (25.0)37 (22.6)0.74
 Nonsevere9 (75.0)127 (77.4)
Diabetes mellitus
 No9 (75.0)132 (80.5)0.71
 Yes3 (25.0)32 (19.5)
Hypertension
 No8 (66.7)87 (53.1)0.55
 Yes4 (33.3)77 (47.0)
Chronic kidney disease
 No10 (83.3)143 (87.2)0.66
 Yes2 (16.7)21 (12.8)
Cancer
 No10 (83.3)136 (82.9)0.99
 Yes2 (16.7)28 (17.1)
Immunosuppression
 No10 (83.3)138 (84.2)0.99
 Yes2 (16.7)26 (15.9)
Recent hospitalization
 No9 (75.0)92 (56.1)0.24
 Yes3 (25.0)72 (43.9)
Recent surgery
 No12 (100.0)152 (92.7)0.99
 Yes0 (0.0)12 (7.3)
Route of FMT delivery
 Colonoscopy5 (41.7)36 (22.0)0.3
 Enema2 (16.7)63 (38.4)
 Nasogastric tube5 (41.7)62 (37.8)
 PEG0 (0.0)3 (1.8)

FMT: fecal microbiota transplantation; PEG: percutaneous endoscopic gastrostomy.